Clinical Trials Insight: 700028805

Trial Profile

Clinical Trials Insight: 700028805

Phase of Trial: Phase II

Latest Information Update: 14 Dec 2007

At a glance

  • Drugs Bevacizumab; Erlotinib; IMO 2055
  • Indications Non-small cell lung cancer
  • Focus Therapeutic Use
  • Sponsors Idera Pharmaceuticals
  • Most Recent Events

    • 14 Dec 2007 Status changed from initiated to recruiting according to Idera Pharmaceuticals media release.
    • 26 Nov 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top